Recently, Mr. Fang Fangshuo, a key partner from Russia, accompanied by translator Ms. Zhang, visited WixBio for detailed discussions on product customization and technical cooperation, ending with a signed letter of intent to collaborate. This visit marks a major step in strengthening their animal health partnership and sets the stage for closer future collaboration.
During the visit, Mr. Fang explored WixBio’s R&D capabilities, production facilities, and quality control systems in depth. Both sides had detailed discussions on tailoring products to meet the Russian market’s specific needs, focusing on the suitability and market potential of vaccines for avian influenza and Newcastle disease. Technical cooperation was also a major focus, covering advancements in vaccine technology, production process improvements, and potential future collaboration models.
WixBio showed off its state-of-the-art production equipment and strict quality management system, highlighting its ongoing commitment to product quality and safety. The two parties also discussed boosting product competitiveness through technology transfer and joint R&D to address the diverse needs of customers across different regions.
After a series of productive talks, WixBio and Mr. Fang agreed on a wide range of cooperative efforts and formally signed the letter of intent. This agreement spans multiple areas of collaboration, aiming to combine their strengths to advance the animal health industry.
WixBio stated: “We’re thrilled about this partnership with our Russian colleagues. It’s not just a nod to our technology and products but also a big step toward sustainable growth of global livestock farming. We’ll keep providing top-quality, efficient services and support to achieve shared success.”
This visit and agreement highlight another milestone in WixBio’s global growth and open a new chapter in China-Russia animal health collaboration. Looking ahead, both sides will work together to explore more opportunities, contributing to the progress of global agriculture and livestock industries.
About WixBio:
WixBio specializes in the R&D, production, and sales of veterinary drugs and animal vaccines. With cutting-edge technology and strict quality controls, it’s a trusted brand for farmers worldwide. Focused on customer-driven innovation, it aims to be a top global partner in animal health.
